文献速递MDS 与骨髓增殖性肿瘤白血病

SRSF2 P95H突变髓系肿瘤中CSF3R的可变剪接异构体

Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms.
PubMed 文献 · Leukemia · 2022-08-08

研究探讨了骨髓增生异常综合征(MDS)相关剪接因子SRSF2对集落刺激因子3受体(CSF3R)III型和IV型异构体表达的影响及其在粒系造血中的作用。在Csf3r缺失小鼠祖细胞中回补IV型异构体增加粒细胞祖细胞但中性粒细胞分化受损,回补III型产生数量减少的形态异常中性粒细胞。携带SRSF2突变的髓系肿瘤患者中这些异构体升高,体外剪接实验证实SRSF2 P95突变与CSF3R小基因共表达增加III型和IV型转录本。

要点

  • SRSF2 P95H通过结合CSF3R外显子17的关键ESE序列促进IV型剪接。
  • IV型异构体回补增加粒细胞祖细胞但中性粒细胞分化受损。
  • III型异构体回补产生数量减少的形态异常中性粒细胞。

核心结论

  • SRSF2 P95H通过结合CSF3R外显子17的关键ESE序列促进IV型剪接,突变型SRSF2参与粒系分化异常。

研究设计与样本

  • 在Csf3r缺失小鼠祖细胞中进行回补实验,在K562细胞中进行体外剪接实验,并在CD34+细胞中表达SRSF2 P95H。

主要发现

  • Csf3r缺失小鼠祖细胞回补IV型异构体增加粒细胞祖细胞但中性粒细胞分化受损,回补III型产生数量减少的形态异常中性粒细胞。
  • 携带SRSF2突变的髓系肿瘤患者中CSF3R III型和IV型异构体升高。
  • K562细胞中SRSF2 P95突变与CSF3R小基因共表达增加III型和IV型转录本。
  • 删除CSF3R外显子17中任一ESE基序降低IV型转录本水平而不影响III型。
  • 表达SRSF2 P95H的CD34+细胞对G-CSF反应的中性粒细胞分化受损,伴随IV型水平升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alternatively spliced colony stimulating factor 3 receptor (CSF3R) isoforms Class III and Class IV are observed in myelodysplastic syndromes (MDS), but their roles in disease remain unclear. We report that the MDS-associated splicing factor SRSF2 affects the expression of Class III and Class IV isoforms and perturbs granulopoiesis. Add-back of the Class IV isoform in Csf3r-null mouse progenitor cells increased granulocyte progenitors with impaired neutrophil differentiation, while add-back of the Class III produced dysmorphic neutrophils in fewer numbers. These CSF3R isoforms were elevated in patients with myeloid neoplasms harboring SRSF2 mutations. Using in vitro splicing assays, we confirmed increased Class III and Class IV transcripts when SRSF2 P95 mutations were co-expressed with the CSF3R minigene in K562 cells. Since SRSF2 regulates splicing partly by recognizing exonic splicing enhancer (ESE) sequences on pre-mRNA, deletion of either ESE motifs within CSF3R exon 17 decreased Class IV transcript levels without affecting Class III. CD34+ cells expressing SRSF2 P95H showed impaired neutrophil differentiation in response to G-CSF and was accompanied by increased levels of Class IV. Our findings suggest that SRSF2 P95H promotes Class IV splicing by binding to key ESE sequences in CSF3R exon 17, and that SRSF2, when mutated, contributes to dysgranulopoiesis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Wang BA, Mehta HM, Penumutchu SR, et al. Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms. Leukemia. 2022. PMID: 35941213. doi:10.1038/s41375-022-01672-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。